Off-the-Shelf immune cells take on Hard-to-Treat cancers
Disease control
Recruiting now
This early-stage trial is testing NK042, a ready-made natural killer cell therapy made from healthy donors, in 76 people with advanced solid tumors that have not responded to standard treatments. Participants first receive chemotherapy to prepare their immune system, then an infu…
Phase: PHASE1 • Sponsor: Shanghai NK Cell Technology Co., LTD • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC